Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Sarepta Therapeutics Inc’s current trading price is -87.39% away from its 52-week high, while its distance from the 52-week low is 74.65%. The stock’s price range over this period has fluctuated between $10.41 and $144.22. The company, operating within the financial sector, had a trading volume of approximately 6.19 million for the day, which was noticeably lower than the average daily share volume of 11.37 million over the last 3 months.
The stock of Sarepta Therapeutics Inc (SRPT) is currently priced at $18.19. In the last session, the stock climbed significantly, topping out at $80.0 after opening at $18.23. The day’s lowest price was $5.0 before the stock closed at $18.23.
Sarepta Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $144.22 on 08/22/24 and the lowest value was $10.41 on 07/24/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Sarepta Therapeutics Inc (SRPT) has experienced a quarterly decline of -49.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.78B and boasts a workforce of 1372 employees.
Sarepta Therapeutics Inc: What Analysts Are Saying
As of right now, 4 analysts are rating Sarepta Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 18 analysts are recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 3 analysts are rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 37.89, with a change in price of -55.18. Similarly, Sarepta Therapeutics Inc recorded 8,510,339 in trading volume during the last 100 days, posting a change of -75.03%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for SRPT stands at 1.00. Similarly, the long-term debt-to-equity ratio is also 1.00.
SRPT Stock Stochastic Average
Today, Sarepta Therapeutics Inc’s raw stochastic average for the past 50 days stands at 23.73%, indicating a decline from the raw stochastic average of the last 20 days, which was 63.88%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 62.43% and 57.35% respectively.
SRPT Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -87.01% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -83.73%. Over the past 30 days, the price of SRPT has fallen by 0.11%. And in the last five days, it has surged by 6.37%.
